[Other] Durvalumab or pembrolizumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy for advanced cholangiocarcinoma: A meta-analysis.

Majoy Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-09-13 02:31
Reward30points

journal:Journal of Clinical Oncology

Authors:Abdullah Esmail; Saifudeen Abdelrahim; Yazan Hamadneh; Nour Maher Mustafa; Ebtesam Al-Najjar; Maen Abdelrahim

Published date:2026-6-1

DOI:10.1200/jco.2026.44.16_suppl.4160

PDF link:https://ascopubs.org/doi/pdfdire ... 26.44.16_suppl.4160

Article link:https://doi.org/10.1200/jco.2026.44.16_suppl.4160

Article Source:American Society of Clinical Oncology (ASCO)


Remark: Could you please share the full-text PDF. Thank you

Reply

Use magic Donate Report

All Reply1 Show all posts
礼貌但长工 Post time 9 min. ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    830


Return to the list